LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 73.00 | 17.25 | 41 | 5546 | 0.0074 | 0.1095 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 73.00 | 17.25 | 8332 | 5546 | 1.5021 | 1.1001 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 74.97 | 17.25 | 119 | 5618 | 0.0212 | 0.2603 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 74.97 | 17.25 | 8396 | 5618 | 1.4943 | 1.0986 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 74.97 | 17.25 | 45 | 5618 | 0.0080 | 0.1217 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 74.97 | 17.25 | 8554 | 5618 | 1.5224 | 1.1033 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 76.94 | 17.25 | 126 | 5681 | 0.0222 | 0.2684 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 76.94 | 17.25 | 8679 | 5681 | 1.5276 | 1.1039 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 76.94 | 17.25 | 22 | 5681 | 0.0039 | 0.0295 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 76.94 | 17.25 | 8808 | 5681 | 1.5503 | 1.1076 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 78.91 | 17.25 | 120 | 5730 | 0.0209 | 0.2606 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 78.91 | 17.25 | 8958 | 5730 | 1.5632 | 1.1096 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 78.91 | 17.25 | 18 | 5730 | 0.0031 | 0.0051 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 78.91 | 17.25 | 9006 | 5730 | 1.5716 | 1.1109 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 80.88 | 17.25 | 114 | 5826 | 0.0196 | 0.2521 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 80.88 | 17.25 | 9122 | 5826 | 1.5657 | 1.1097 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 80.88 | 17.25 | 10 | 5826 | 0.0017 | -0.0629 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 80.88 | 17.25 | 9246 | 5826 | 1.5870 | 1.1130 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 82.85 | 17.25 | 113 | 5861 | 0.0193 | 0.2505 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 82.85 | 17.25 | 9423 | 5861 | 1.6076 | 1.1162 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 82.85 | 17.25 | 7 | 5861 | 0.0012 | -0.1017 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 82.85 | 17.25 | 9473 | 5861 | 1.6161 | 1.1175 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 84.82 | 17.25 | 104 | 5924 | 0.0176 | 0.2377 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 84.82 | 17.25 | 9740 | 5924 | 1.6441 | 1.1216 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 84.82 | 17.25 | 4 | 5924 | 0.0007 | -0.1593 | MN20160310_N02 | N21 |